News

Filter

Current filters:

Glycopyrrolate

Sciele's drooling drug meets Ph III endpoints

22-09-2008

USA-based Sciele Pharma has completed a pivotal Phase III program to support a New Drug Application filing…

GlycopyrrolateRobinulShionogi

Sciele completes Ph III drool-drug trial

14-07-2008

US drugmaker Sciele Pharma has completed a Phase III safety trial of liquid formulation gylcopyrrolate…

GlycopyrrolateRobinul

Sciele Pharma begins enrollment in Ph II

16-04-2007

USA-based Sciele Pharma, formerly known as the First Horizon Pharmaceutical Corp, says that it has begun…

GlycopyrrolateRobinul

First Horizon's glycopyrrolate gets OD designation

26-06-2006

USA-based First Horizon Pharmaceutical Corp says that the Food and Drug Administration has granted Orphan…

GlycopyrrolateRobinul

Horizon acquires Robinul and Robinul Forte from Wyeth-Ayerst

04-02-1999

- Horizon Pharmaceutical Corp has acquired Robinul (glycopyrrolate)and Robinul Forte in the USA from…

GlycopyrrolateRobinulWyeth

COMPANY SPOTLIGHT

Menarini

Back to top